Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/58309

Type
Article
Copyright
Restricted access
Embargo date
2075-12-31
Sustainable Development Goals
03 Saúde e Bem-Estar
10 Redução das desigualdades
 
Collections
Share

Statistics
Metadata
Show full item record

COVID-19 IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A 2-YEAR STUDY OF INCIDENCE AND MORTALITY IN RELATION TO THE VARIANTS OF CONCERN WAVES IN BRAZIL
Almeida, Nathalie Bonatti Franco et al. | Date Issued: 2023
Author
Almeida, Nathalie Bonatti Franco
Filgueiras, Priscilla Soares
Lourenço, Adelina Júnia
Bicalho, Cecilia Maria Florencio
Corsini, Camila Amormino
Miranda, Daniel Alvim Pena de
Contin, Sarah Vieira Marques
Vilela, Raquel Virgínia Rocha
Queiroz, Rafaella Fortini Grenfell e
Affilliation
Fundação Oswaldo Cruz. Instituto René Rachou. Diagnóstico e Terapia de Doenças Infecciosas e Câncer. Belo Horizonte, MG, Brasil / University of Georgia. College of Veterinary Medicine. Department of Infectious Diseases. Athens, GA, USA.
Fundação Oswaldo Cruz. Instituto René Rachou. Diagnóstico e Terapia de Doenças Infecciosas e Câncer. Belo Horizonte, MG, Brasil / Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Belo Horizonte, MG, Brasil.
Fundação Benjamin Guimarães. Hospital da Baleia. Belo Horizonte, MG, Brasil.
Fundação Benjamin Guimarães. Hospital da Baleia. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto René Rachou. Diagnóstico e Terapia de Doenças Infecciosas e Câncer. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto René Rachou. Diagnóstico e Terapia de Doenças Infecciosas e Câncer. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto René Rachou. Diagnóstico e Terapia de Doenças Infecciosas e Câncer. Belo Horizonte, MG, Brasil.
Fundação Benjamin Guimarães. Hospital da Baleia. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto René Rachou. Diagnóstico e Terapia de Doenças Infecciosas e Câncer. Belo Horizonte, MG, Brasil / University of Georgia. College of Veterinary Medicine. Department of Infectious Diseases. Athens, GA, USA / Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Belo Horizonte, MG, Brasil.
Abstract
Background: Chronic kidney disease (CKD) is a risk factor for severe coronavirus disease (COVID-19). In Brazil, the disease is the 10th highest cause of death. We evaluated the epidemiological impact of COVID-19 in CDK and non-CDK patients. Methods: Positive patients for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from 2020 to 2022 were classified according to the severity of COVID-19 and the numbers of cases and deaths were correlated to each wave of SARS-CoV-2 variants in Brazil. Results: We compared all variables, and our data show that CDK significantly increased the mortality rate among patients, especially before COVID-19 vaccination, in comparison with non-CKD patients. Conclusions: CKD patients had a significantly increased mortality rate compared with non-CKD.
Keywords
Chronic kidney disease
COVID-19
Vaccines
Mortality
SARS-CoV-2
Variants of concern
 
Publisher
Oxford University Press
Citation
ALMEIDA, Nathalie Bonatti Franco et al. COVID-19 in patients with chronic kidney disease: a 2-year study of incidence and mortality in relation to the variants of concern waves in Brazil. Transactions of The Royal Society of Tropical Medicine and Hygiene, v. 117, n. 8, p. 606-608, 12 Apr. 2023.
DOI
10.1093/trstmh/trad019
ISSN
0035-9203